Vaccines are risky or ineffective in people with compromised immune systems, they don’t even exist for several viral diseases. All of which gave scientists in half a dozen labs the same idea: Rescue one of the oldest biotechnologies with one of the newest — CRISPR.
Immune cells which could fight all kinds of influenza virus have been discovered by scientists, raising hope for a universal vaccine which does not need to be update annually.
The plan seeks to prevent and control bird flu outbreaks and help form disease-free poultry farming zones and chains, thus minimizing the disease's impact on Vietnam's public health, food safety, and trading activities.
The current study investigated the immunogenicity and protective response of rPA antigen formulated with the DPXTM no-release delivery platform (DPX-rPA). This unique formulation promotes a depot effect that attracts antigen-presenting cells to the vaccination site and elicits an immune response following single-dose delivery.
Doctors Without Borders/Médecins Sans Frontières (MSF) will participate in an ongoing randomized controlled trial of four potential Ebola treatments in North Kivu, Democratic Republic of Congo, in collaboration with the Ministry of Health, the international medical humanitarian organization said Tuesday.
Researchers have developed a mathematical framework to estimate the value of investing in developing and conserving an antibiotic to mitigate the burden of bacterial infections caused by resistant Staphylococcus aureus during a pandemic influenza outbreak.
Vaccine development for challenging diseases like Ebola and Marburg viruses remains a very difficult task. The pace at which the rVSV-ZEBOV vaccine has been developed and implemented, in addition to the effectiveness of the ring vaccination strategy, has paved a way for dealing with future outbreaks.
A novel, synthetic DNA vaccine developed at the Wistar Institute induces protective immunity against Mayaro virus (MAYV), a mosquito-borne infection endemic to South America, that has the potential to become a global emerging viral threat.
Severe fever with thrombocytopenia virus is an emerging tick-borne arbovirus first reported in East and Central China in 2009, and subsequently in Korea and Japan. A closely related virus, termed Heartland virus, was identified and isolated from two patients in the US in 2012.
Researchers are worried about the fast development and spread of "superbugs," which are bacteria that do not respond to antibiotics. For the first time, scientists have found potent superbugs in the remote High Arctic of Norway, which they fear does not bode well for the future of antibiotic treatments.